Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)
NCT02110264
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
151
Enrollment
OTHER
Sponsor class
Conditions
Opioid Use Disorders
Interventions
DRUG:
XR-NTX
BEHAVIORAL:
XR-NTX+PN
BEHAVIORAL:
ETAU
Sponsor
University of California, Los Angeles
Collaborators
[object Object]